First Farmers and Merchants Corporation Declares Quarterly Cash Dividend of $0.24 Per Share
Contacts Robert E. Krimmel Chief Financial Officer (931) 380-8257 First Farmers and Merchants Corporation (OTC Pink: FFMH), the holding company...
Month: March 2024
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Contacts Investor Relations Contact: Caroline Corner investors@personalis.com 415-202-5678 Media: pr@personalis.com Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for...
Forza X1, Inc. Announces Year End 2023 Financial Results Call on March 26
FORT PIERCE, FL / ACCESSWIRE / March 19, 2024 / Forza X1, Inc. (NASDAQ:FRZA) ("Forza," the "Company"), a developer of...
Farmers & Merchants Bancorp, Inc. Declares 2024 First-Quarter Cash Dividend
ARCHBOLD, Ohio, March 19, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Farmers & Merchants Bancorp, Inc., (Nasdaq: FMAO)...
Twin Vee PowerCats Co. Announces Year End 2023 Earnings Call on March 26
FORT PIERCE, FL / ACCESSWIRE / March 19, 2024 / Twin Vee PowerCats, Co. (Nasdaq:VEEE),("Twin Vee" or the "Company"), a...
Tempest Reports Year End 2023 Financial Results and Provides Business Update
BRISBANE, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted...
Tivic Health to Report 2023 Year-End Financial Results on March 25th Via Conference Call and Webcast
Contacts Investor Contact: Hanover International, Inc. ir@tivichealth.com Tivic Health® Systems, Inc. (“Tivic Health”) (Nasdaq: TIVC), a health tech company that...
Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 – 27, 2024
LOWELL, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences...
NXP Publishes Annual Corporate Sustainability Report, Highlights Progress Toward Environmental, Social and Governance Goals
EINDHOVEN, The Netherlands, March 19, 2024 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI) has published its annual Corporate Sustainability...
Neogen Announces Third-Quarter Earnings Release Date
LANSING, Mich., March 19, 2024 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) will issue its third-quarter earnings release before the opening...
Moleculin Announces Reverse Stock Split
HOUSTON, March 19, 2024 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company...
Fulton Financial Corporation Declares Common and Preferred Dividends
Contacts Media: Rachel Sharkey (717) 291-2831 Investors: Matt Jozwiak (717) 327-2657 Fulton Financial Corporation (“Fulton”) (Nasdaq: FULT) today announced that...
Bridger Aerospace Announces Record 2023 Results; Provides Outlook for 2024 Growth
BELGRADE, Mont., March 19, 2024 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ:...
Bridger Aerospace Announces Record 2023 Results; Provides Outlook for 2024 Growth
BELGRADE, Mont., March 19, 2024 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ:...
Skyharbour’s Partner Azincourt Energy Begins Mobilizing for Winter Drill Program at East Preston Uranium Project
VANCOUVER, British Columbia, March 19, 2024 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd.’s (TSX-V:SYH) (OTCQX:SYHBF) (Frankfurt:SC1P) (the “Company”) partner company Azincourt...
Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
CORAL GABLES, Fla., March 19, 2024 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the...
Oblong Announces Financial Results for Fourth Quarter 2023 and Provides Business Update
Contacts Investor Relations Contact David Clark investors@oblong.com (213) 683-8863 ext. 5 Oblong, Inc. (Nasdaq: OBLG) (“Oblong” or the “Company”), an...
Joseph W. Adams Joins Wayne Bank as Senior Vice President
HONESDALE, Pa., March 19, 2024 (GLOBE NEWSWIRE) -- Jim Donnelly, President and CEO of Wayne Bank, announced the appointment of...
Mitek Reports Record Revenue and Earnings for Fiscal 2023
Total Revenue for Fiscal 2023 Increased 19% Year Over Year; Company Reiterates Guidance for Fiscal 2024 Contacts Investor Contact: Todd...
Landsea Homes Announces Pricing of Private Offering of Senior Notes
DALLAS, March 19, 2024 (GLOBE NEWSWIRE) -- Landsea Homes Corporation (Nasdaq: LSEA) (“Landsea Homes” or the “Company”) announced today that...
Intrusion, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on Tuesday, March 26, 2024
PLANO, TX / ACCESSWIRE / March 19, 2024 / Intrusion, Inc. (NASDAQ:INTZ), a leader in cyberattack prevention solutions, will release...
Inspired Entertainment, Inc. Appoints Simona Camilleri as General Counsel
NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) -- Inspired Entertainment, Inc. (“Inspired” or the “Company”) (NASDAQ: INSE), a leading B2B...
GDEV announces preliminary unaudited results for the fourth quarter and full year 2023
LIMASSOL, Cyprus, March 19, 2024 (GLOBE NEWSWIRE) -- GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company (“GDEV” or...
Gambling.com Group Secures New $50 Million Credit Facility
Contacts Investors: Peter McGough, Gambling.com Group, investors@gdcgroup.com or Richard Land, Norberto Aja, JCIR, GAMB@jcir.com Media: Eddie Motl, Gambling.com Group, media@gdcgroup.com...
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
Conference Call and Webcast March 20 at 8:00 AM Eastern Time / 7:00 AM Central Time ReMEDy2 Clinical Site Activation...
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
– On Track to Start Oral Fadraciclib Phase 2 Proof of Concept in 1H 2024 –– Expect to Report Final Data from Fadraciclib...
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
– On Track to Start Oral Fadraciclib Phase 2 Proof of Concept in 1H 2024 –– Expect to Report Final Data from Fadraciclib...
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Soquelitinib advancing towards initial enrollment for registrational Phase 3 clinical trial for PTCL and randomized Phase 1 clinical trial for...
China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement
HANGZHOU, China, March 19, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading...
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
WARREN, N.J., March 19, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (Nasdaq: AQST) (the “Company” or “Aquestive”), a pharmaceutical company...
AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
Contacts Investor Contact: AngioDynamics, Inc. Stephen Trowbridge, Executive Vice President & CFO (518) 795-1408 AngioDynamics, Inc. (NASDAQ: ANGO), a leading...
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
Expanded clinical pipeline into autoimmune diseases with U.S. Food and Drug Administration (FDA) clearance of Investigational New Drug Application (IND)...
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2023 Financial Results on March 26, 2024
CHARLOTTESVILLE, Va., March 19, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical...
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
Contacts Media: Kathleen Reid; media@abcellera.com, +1(236)521-6774 Business Development: Murray McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005 Investor Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116 AbCellera...
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
EMERYVILLE, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- As previously announced on February 16, 2024, XOMA Corporation (“XOMA” or the...
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
EMERYVILLE, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- As previously announced on February 16, 2024, XOMA Corporation (“XOMA” or the...
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
EMERYVILLE, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- As previously announced on February 16, 2024, XOMA Corporation (“XOMA” or the...
TeraWulf Reports Fourth Quarter and Full Year 2023 Results
Annual Revenue Grows 360% Year-Over-Year; Annual BTC Self-Mined Increases 550% to 3,407Reports Realized Cost of Power of 3.2 Cents Per...
Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights
- Advanced SURF301 Phase 1 oncology study; Initial Phase 1 results to be reported in 2H 2024 -- TYRA-300 Phase...
Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates
Data from first adult patient in REVEAL Phase 1/2 trial showed TSHA-102 (low dose, 5.7x1014 total vg) was well-tolerated with...